Procter & Gamble director receives RSU grant; 43.4k shares owned
Rhea-AI Filing Summary
Terry J. Lundgren, a director of Procter & Gamble (PG), was awarded 220 restricted stock units (RSUs) on 09/09/2025 under the company's 2019 Stock and Incentive Compensation Plan. The RSUs were granted at a $0 per-share price as dividend-equivalent RSUs and are reported as 220 units added to his holdings. Following the transaction, Mr. Lundgren beneficially owns a total of 43,397.6912 shares, which includes RSU dividend equivalents and shares from the issuer's dividend reinvestment plan. Additionally, 530 shares are reported as indirectly held by his spouse.
Positive
- Director alignment: Receipt of 220 RSUs reinforces alignment of the director's interests with shareholders through equity compensation.
- Increased beneficial ownership: Total reported beneficial ownership of 43,397.6912 shares (including dividend reinvestment) indicates substantial existing stake.
Negative
- None.
Insights
TL;DR: Director received a modest RSU grant, increasing beneficial ownership to ~43.4k shares; includes dividend equivalents and spousal holdings.
The filing documents a non-cash equity award to a sitting director under the company's incentive plan, recorded as 220 RSUs. The grant price is reported as $0 because these units are dividend equivalents rather than an open-market purchase. The reporting aggregates multiple sources of ownership including dividend reinvestment plan shares, resulting in a total beneficial position of 43,397.6912 shares. Spousal indirect ownership of 530 shares is separately disclosed, consistent with Section 16 reporting rules.
TL;DR: Transaction is routine director compensation in equity form; it modestly increases insider stake but presents no cash flow or dilution signal.
The movement reflects a typical equity grant to align director interests with shareholders. The RSU grant size (220 units) is small relative to the reported total beneficial ownership, indicating a marginal change in insider exposure. The $0 price notation and explanatory text confirm these are dividend-equivalent RSUs and reinvested dividends, not an open-market acquisition. No derivative transactions or dispositions are reported.